Patent Opposition Database

Pneumococcal Conjugate Vaccine (PCV)

Type: Drug Disease: Pneumonia Countries: India and Korea (Republic of) Related documents: 21

Abacavir (ABC)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Abacavir/Lamivudine (ABC/3TC)

Type: Drug Disease: HIV/AIDS Countries: Europe (EPO) Related documents: 1

Amprenavir (AMP)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 5

Atazanavir (ATV)

Type: Drug Disease: HIV/AIDS Countries: Brazil and India Related documents: 14

Atorvastatin (Atorvastatin)

Type: Drug Disease: Cholesterol Countries: Dominican Republic Related documents: 2

Bedaquiline (BDQ)

Type: Drug Disease: Tuberculosis Countries: Brazil, Europe (EPO), India, Thailand, and Ukraine Related documents: 23

Bedaquiline, Pretomanid and Linezolid (BPaL)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 3

Benzylguanidine (BG)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 1

CRISPR/Cas9 (CRISPR/Cas9)

Type: Drug Disease: Various Countries: Colombia Related documents: 1

Cabotegravir (.CAB)

Type: Drug Disease: HIV Countries: India Related documents: 4

Carvedilol+Hydrochlorothiazide (CAR + HCTZ)

Type: Drug Disease: Heart disease Countries: Argentina Related documents: 1

Celecoxib (CLX)

Type: Drug Disease: Osteoarthritis Countries: Argentina Related documents: 1

Cetirizine (CTZ)

Type: Drug Disease: Asthma Countries: Argentina Related documents: 1

Cyclobenzaprine (C)

Type: Drug Disease: Sleeping disorder Countries: Argentina Related documents: 2

DPP-4 inhibitors (DPP-4 )

Type: Drug Disease: Diabetes Countries: Dominican Republic Related documents: 1

Daclatasvir (BMS 790052)

Type: Drug Disease: Hepatitis C Countries: Brazil and India Related documents: 21

Darunavir (DRV)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 9

Darunavir+Ritonavir (DRV/r)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Dasatinib (DAS)

Type: Drug Disease: Chronic Myeloid Leukaemia Countries: India Related documents: 6

Delamanid (Delamanid)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 4

Descarboethoxyloratadine (DCL)

Type: Drug Disease: Allergy Countries: Argentina Related documents: 2

Didanosine (ddl)

Type: Drug Disease: HIV/AIDS Countries: Thailand Related documents: 1

Dolutegravir (DTG)

Type: Drug Disease: Countries: Brazil and India Related documents: 9

Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC)

Type: Drug Disease: HIV Countries: Europe (EPO) and Thailand Related documents: 5

Efavirenz (EFV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 3

Elvitegravir (EVG)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 2

Emtricitabine (FTC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Enfuvirtide (enfuvirtide)

Type: Drug Disease: HIV/AIDS Related documents: 0

Enzalutamide (ezm)

Type: Drug Disease: Prostate cancer Countries: India Related documents: 10

Etanercept/Infliximab/Adalimumab (ETN/IFX/ADA)

Type: Drug Disease: Rheumatoid arthritis Countries: Argentina Related documents: 1

Etravirine (ETV)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 1

Favipiravir (T-705)

Type: Drug Disease: Viral infection - Influenza Countries: Thailand Related documents: 1

Fexofenadine + cyclodextrins (FEX + CYD)

Type: Drug Disease: Rhinitis Countries: Argentina Related documents: 1

Fosamprenavir (FPV, f-APV)

Type: Drug Disease: HIV/AIDS Related documents: 0

GSK3036656 (GSK656)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 2

Gamma-aminobutyric acid (GABA)

Type: Drug Disease: Cerebral disease Countries: Argentina Related documents: 1

Glatiramer acetate (GLA)

Type: Drug Disease: Multiple sclerosis Countries: India Related documents: 2

Glecaprevir (GLE)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Imatinib (ITB)

Type: Drug Disease: Cancer Countries: India Related documents: 6

Indinavir (IDV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Interferon (IFN)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 1

Islatravir (MK-8591)

Type: Drug Disease: HIV Countries: Ukraine Related documents: 1

Isoniazid-Rifapentine (3HP (Isoniazid-Rifapentine )

Type: Drug Disease: Latent Tuberculosis Infection Countries: Europe (EPO), India, and Thailand Related documents: 9

Lamivudine (3TC)

Type: Drug Disease: HIV/AIDS Countries: Spain Related documents: 1

Lamivudine/Stavudine (3TC/d4T)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lamivudine/Stavudine + efavirenz (3TC/d4T + EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lamivudine/Stavudine/Nevirapine (3TC/d4T/NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lapatinib ditosylate (GW572016)

Type: Drug Disease: Cancer Countries: India Related documents: 1

Ledipasvir (LDV)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Ledipasvir+Ribavirin+Other Anti-HCV Compounds (GS5885+RBV+other Anti-HCV Compounds)

Type: Drug Disease: Hepatitis C Related documents: 1

Lenacapavir (GS-6207)

Type: Drug Disease: HIV Countries: India Related documents: 2

Linezolid (Lzd)

Type: Drug Disease: Tuberculosis Countries: India and South Africa Related documents: 4

Lopinavir (LPV)

Type: Drug Disease: HIV/AIDS Countries: Argentina, India, and Kazakhstan Related documents: 12

Lopinavir/Ritonavir (LPV/r)

Type: Drug Disease: HIV/AIDS Countries: Belarus, Brazil, India, Ukraine, and Viet Nam Related documents: 31

Maraviroc (MVC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Nadifloxacin (NDFX)

Type: Drug Disease: Dermatological disease Countries: Argentina Related documents: 1

Nelfinavir (NFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Neurokinin antagonist/H1 antagonist/H2 antagonists (NK1/ H1A/ H2A)

Type: Drug Disease: Asthma Countries: Argentina Related documents: 1

Nevirapine (NVP)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 7

Nilotinib (NILO)

Type: Drug Disease: Chronic Myeloid Leukaemia Countries: India Related documents: 3

Nusinersen ((Spinraza))

Type: Drug Disease: spinal muscular atrophy (SMA Countries: Colombia Related documents: 1

OPC-167832 (3,4-dihydrocarbostyril derivative (OPC-167832)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 2

Paclitaxel (PTX)

Type: Drug Disease: Cancer Countries: India Related documents: 3

Pibrentasvir (PIB)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Quinolone (QN)

Type: Drug Disease: Eye disease Countries: Argentina Related documents: 1

Quinolone/Nonsteroidal anti-inflammatory drugs (QN/NSAID)

Type: Drug Disease: Eye disease Countries: Argentina Related documents: 1

Raltegravir (RAL)

Type: Drug Disease: HIV/AIDS Countries: Argentina, India, and Thailand Related documents: 8

Remdesivir (GS-5734 (RDV)

Type: Drug Disease: Covid-19 Countries: Argentina and India Related documents: 6

Resveratrol + L-carnitine (RSV)

Type: Drug Disease: Cerebral disease Countries: Argentina Related documents: 1

Rilpivirine (TMC 278)

Type: Drug Disease: HIV/AIDS Related documents: 0

Ritonavir (r, RTV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 16

Rosuvastatin (ZD-4522)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 11

Saquinavir (SQV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Simepravir (TMC 435)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Simeprevir (TMC 435)

Type: Drug Disease: Hepatitis C Related documents: 0

Sofosbuvir (GS7977)

Type: Drug Disease: Hepatitis C Countries: Argentina, Brazil, China, Europe (EPO), India, Korea (Republic of), Russian Federation, Ukraine, United States of America, and Viet Nam Related documents: 59

Sofosbuvir + Ledipasvir (GS7977+GS5885)

Type: Drug Disease: Hepatitis C Countries: Brazil, Colombia, India, and Ukraine Related documents: 4

Sofosbuvir+Ribavirin (GS7977+RBV)

Type: Drug Disease: Hepatitis C Countries: United States of America Related documents: 1

Sofosbuvir/Velpatasvir (SOF/VEL)

Type: Drug Disease: Hepatitis C Countries: China and India Related documents: 4

Sorafenib (SOR)

Type: Drug Disease: Hepatocellular Carcinoma (liver cancer Countries: India Related documents: 7

Stavudine (d4T)

Type: Drug Disease: HIV/AIDS Related documents: 0

Sunitinib (SU)

Type: Drug Disease: Cancer Countries: India Related documents: 4

Sutezolid (PNU-100480)

Type: Drug Disease: Tuberculosis Countries: Brazil and United States of America Related documents: 4

Telacebec (Q203 (Q203)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 2

Teneligliptin (CS-0882)

Type: Drug Disease: Diabetes Countries: India Related documents: 2

Tenofovir Alafenamide Fumarate (TAF)

Type: Drug Disease: HIV Countries: Brazil, India, Thailand, and Ukraine Related documents: 11

Tenofovir disoproxil fumarate (TDF)

Type: Drug Disease: HIV/AIDS Countries: Brazil and India Related documents: 24

Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC)

Type: Drug Disease: HIV/AIDS Countries: Argentina, Brazil, India, and Thailand Related documents: 14

Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz (TDF/FTC/EFV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 7

Tenofovir disoproxil fumarate/Lamivudine (TDF/3TC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tenofovir disoproxil fumarate/Lamivudine + nevirapine (TDF/3TC + NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tenofovir disoproxil fumarate/Lamivudine/Efavirenz (TDF/3TC/EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tipranavir (TPV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tisagenlecleucel (Adoptive immunotherapy agent CTL019)

Type: Drug Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO) Related documents: 5

Valganciclovir (VAL)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 11

Velpatasvir (GS5816)

Type: Drug Disease: Hepatitis C Countries: Brazil, China, and India Related documents: 7

Zidovudine (AZT, ZDV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Zidovudine/Lamivudine (AZT/3TC)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Zidovudine/Lamivudine + efavirenz (AZT/3TC + EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Zidovudine/Lamivudine/Abacavir (AZT/3TC/ABC)

Type: Drug Disease: HIV/AIDS Countries: United States of America Related documents: 1

Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Linezolid (Lzd) application, (WO/2001/057035)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: South Africa

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/151760)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine decision, (8081/DELNP/2007)

Type: Patent office decision Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

lapatinib ditosylate (GW572016) application, (WO/2002/02552)

Type: Patent application Drugs: Lapatinib ditosylate Disease: Cancer Countries: India

100 Percent Life opposition, bedaquiline, (PCT/EP2016/051545)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Ukraine

5569760 prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

ABIA opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

ABIA opposition, TAF, (PI0112646-6)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Bedaquiline, (TH0501002434)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Bedaquiline, (TH0701006189)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Dolutegravir/Abacavir/Lamivudine , (TH1201003753)

Type: Patent opposition Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Thailand

AIDS Access Foundation opposition, Bedaquiline, (TH0501005795)

Type: Patent opposition Drugs: Bedaquiline Disease: Latent Tuberculosis Infection Countries: Thailand

AIDS Access Foundation opposition, Bedaquiline, (TH170100416)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS Access Foundation opposition, Favipiravir , (TH1101001988)

Type: Patent opposition Drugs: Favipiravir Disease: COVID 19 Countries: Thailand

AIDS Access Foundation opposition, Isoniazid-Rifapentine (3HP), (PCT/EP2014/065762)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Tuberculosis Countries: Thailand

AIDS Access Foundation opposition, Tenofovir Alafenamide Fumarate , (1401000784, PCT/US2012/050920)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV Countries: Thailand

Abacavir/Lamivudine decision, (EP1113803)

Type: Patent office decision Drugs: Abacavir/Lamivudine Disease: Hepatitis B Countries: Europe (EPO)

All-Ukrainian Network of People Living with HIV/AIDS opposition, Islatravir, (WO2017/139519 A1)

Type: Patent opposition Drugs: Islatravir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Lopinavir/Ritonavir, (WO 01/34119)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Lopinavir/Ritonavir, (WO 2005/039551)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir + Ledipasvir, (РСТ/US2012/055621 (a 2014 03617))

Type: Patent opposition Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir, (РСТ/US2011/030725 (а 2012 12444))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir, (РСТ/US2011/044581(а 2013 01999))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate, (75889 (PCT/US01/23104))

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Ukraine

Amrita Majumdar opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Apotex Corp opposition, Zidovudine/Lamivudine/Abacavir, (US6417191)

Type: Patent opposition Drugs: Zidovudine/Lamivudine/Abacavir Disease: HIV/AIDS Countries: United States of America

Atazanavir application, (WO2005108349)

Type: Patent application Drugs: Atazanavir Disease: HIV Countries: Brazil

Atorvastatin decision, (DOP2002000413 in the Dominican Republic; the priority number is US 60/302,049.)

Type: Patent office decision Drugs: Atorvastatin Disease: Cholesterol reduction, cardiovascular diseases Countries: Dominican Republic

Atorvastatin, Amlodipine decision, (DOP2002000445 in the Dominican Republic; the priority number is US 60/309,133.)

Type: Patent office decision Drugs: Atorvastatin Disease: Cholesterol reduction, cardiovascular diseases, chest pain Countries: Dominican Republic

BDR Pharmaceuticals Ltd. opposition, Dasatinib , (4309/DELNP/2006)

Type: Patent opposition Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

BDR Pharmaceuticals Ltd. opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

BDR Pharmaceuticals Ltd. opposition, SOFOSBUVIR, (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

BPaL application, (WO2017/066053)

Type: Patent application Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Bedaquiline (BDQ) application, (WO/2005/117875)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2004/011436)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2004/011436)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2005/117875)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/067048)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/125769)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/131519)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2008/068231 )

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2008/068231)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2008/068231)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Europe (EPO)

Bedaquiline decision, (BR0312927)

Type: Patent office decision Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline decision, (BR0506121)

Type: Patent office decision Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bengal Network of People Living with HIV/AIDS (BNP+) and Firoz Khan opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2182/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2183/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

CILFA opposition, ELVITEGRAVIR, (P050102058)

Type: Patent opposition Drugs: Elvitegravir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Type: Patent opposition Drugs: Gamma-aminobutyric acid Disease: Cerebral disease Countries: Argentina

CILFA opposition, Nadifloxacin, (P990106490)

Type: Patent opposition Drugs: Nadifloxacin Disease: Dermatological disease Countries: Argentina

CILFA opposition, antibióticos de quinolona + compuestos NSAID, (P000103425)

Type: Patent opposition Drugs: Quinolone/Nonsteroidal anti-inflammatory drugs Disease: Eye disease Countries: Argentina

CILFA opposition, antibióticos de quinolona, (P000103426)

Type: Patent opposition Drugs: Quinolone Disease: Eye disease Countries: Argentina

CILFA opposition, benzoilguanidinas (Markush), (P990106043)

Type: Patent opposition Drugs: Benzylguanidine Disease: Diabetes Countries: Argentina

CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Type: Patent opposition Drugs: Carvedilol+Hydrochlorothiazide Disease: Heart disease Countries: Argentina

CILFA opposition, celecoxib, (P990106069)

Type: Patent opposition Drugs: Celecoxib Disease: Osteoarthritis Countries: Argentina

CILFA opposition, cetirizine, (P990104039)

Type: Patent opposition Drugs: Cetirizine Disease: Asthma Countries: Argentina

CILFA opposition, cyclobenzaprine (C) , (P000104189)

Type: Patent opposition Drugs: Cyclobenzaprine Disease: Sleeping disorder Countries: Argentina

CILFA opposition, descarboetoxiloratadina + fosfatodibásico de calcio, (P000103668 divisional of P990103342)

Type: Patent opposition Drugs: Descarboethoxyloratadine Disease: Allergy Countries: Argentina

CILFA opposition, descarboetoxiloratadina, (P000103667 divisional of P990103342)

Type: Patent opposition Drugs: Descarboethoxyloratadine Disease: Allergy Countries: Argentina

CILFA opposition, efavirenz (EFV) , (P990101586)

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: Argentina

CILFA opposition, efavirenz (EFV) , (P990102809)

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: Argentina

CILFA opposition, etanercept, Infliximab, Adalimumab, (P030103906)

Type: Patent opposition Drugs: Etanercept/Infliximab/Adalimumab Disease: Rheumatoid arthritis Countries: Argentina

CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Type: Patent opposition Drugs: Fexofenadine + cyclodextrins Disease: Rhinitis Countries: Argentina

CILFA opposition, lopinavir (LPV) , (P060100645)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, neurokinin antagonist/H1 antagonist/H2 antagonists, (P990105080)

Type: Patent opposition Drugs: Neurokinin antagonist/H1 antagonist/H2 antagonists Disease: Asthma Countries: Argentina

CILFA opposition, raltegravir (RAL) , (P050104911)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, reverastrol + L-carnitine, (P990105115)

Type: Patent opposition Drugs: Resveratrol + L-carnitine Disease: Cerebral disease Countries: Argentina

CILFA opposition, ritonavir (r, RTV) , (P070100928)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, ritonavir (r, RTV) , (P070100929)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, rosuvastatin , (P000104058)

Type: Patent opposition Drugs: Rosuvastatin Disease: Cholesterol Countries: Argentina

CILFA opposition, rosuvastatin, (P000100408)

Type: Patent opposition Drugs: Rosuvastatin Disease: Diabetes Countries: Argentina

CILFA opposition, rosuvastatin, (P000104057)

Type: Patent opposition Drugs: Rosuvastatin Disease: Cholesterol Countries: Argentina

CILFA opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (P060102468)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: Argentina

Cabinet PLASSERAUD opposition, Tisagenlecleucel, (EP3214091)

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO)

Cabotegravir application, (WO/2010/011814)

Type: Patent application Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Cabotegravir application, (WO/2012/037320)

Type: Patent application Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Cancer Patient Aid Association (CPAA) opposition, imatinib (ITB) , (1602/MAS/98 )

Type: Patent opposition Drugs: Imatinib Disease: Cancer Countries: India

Cipla Ltd. opposition, Darunavir and Ritonavir , (1647/DELNP/2004 (WO/2003/049746))

Type: Patent opposition Drugs: Darunavir+Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, Darunavir, (3598/DELNP/2004)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, Sorafenib, (IN/PCT/2001/799/MUM)

Type: Patent opposition Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Cipla Ltd. opposition, atazanavir (ATV) , (2933/DELNP/2009 (Divisional of 6425/DELNP/2006))

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (1647/DELNP/2004)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (2221/DELNP/2008)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (5301/DELNP/2006 (Key Intermediates))

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, sunitinib (su) , (IN/PCT/2002/00785/DEL )

Type: Patent opposition Drugs: Sunitinib Disease: Cancer Countries: India

Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (9661/DELNP/2007)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Colombia, Think-tank: "Medicines, Information and Power" at Universidad Nacional de Colombia. Centro de Pensamiento, Medicamentos, Información y Poder. (O.Lizarazo) opposition, crystalline Sofosbuvir, + amorphous ledipasvir, (WO2014120981 PCT/US2014/013953)

Type: Patent opposition Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: Colombia

DNP+ and I-MAK opposition, Pibrentasvir, (1310/DELNP/2013)

Type: Patent opposition Drugs: Pibrentasvir Disease: Hepatitis C Countries: India

DPP-4 inhibitors decision, (DOP2009000215 in the Dominican Republic; the priority number is US 60/894,624.)

Type: Patent office decision Drugs: DPP-4 inhibitors Disease: Diabetes Countries: Dominican Republic

Daclatasvir application, (WO/2008/021927)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2009/020825)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2009/020828)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2011/059850 )

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO2008021927)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

Daclatasvir (BMS 790052) application, (WO/2008/021928)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir (BMS 790052) application, (WO/2010/120621)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir (BMS790052) application, (WO/2009/102568)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (806/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (854/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Darunavir (DRV) application, (WO/2005/095410)

Type: Patent application Drugs: Darunavir Disease: HIV/AIDS Countries: India

Darunavir application, (WO/2003/106461)

Type: Patent application Drugs: Darunavir Disease: HIV/AIDS Countries: India

Dasatinib application, (WO/2000/062778)

Type: Patent application Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Dasatinib application, (WO/2005/077945)

Type: Patent application Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Dasatinib decision, (IN/PCT/2001/01138/MUM (IN203937))

Type: Patent office decision Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Delamanid application, ( WO/2007/043542)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2004/033463)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2004/033463)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2007/013477)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delhi Network of Positive People (DNP+) opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)

Type: Patent opposition Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Delhi Network of Positive People (DNP+) opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, Sofosbuvir/Velpatasvir, (201627008488)

Type: Patent opposition Drugs: Sofosbuvir/Velpatasvir Disease: Hepatitis C Countries: India

Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (201627039572)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Delhi Network of Positive People (DNP+) opposition, efavirenz (EFV) , (IN/PCT/2000/00553/MUM (granted as: 195367))

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, raltegravir (RAL) , (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People opposition, Lenacapavir, (201917006277)

Type: Patent opposition Drugs: Lenacapavir Disease: HIV Countries: India

Dolutegravir application, (WO/2006/116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Dolutegravir application, (WO/2006/116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Dolutegravir application, (WO2006116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

Dolutegravir/Abacavir/Lamivudine decision, (EP2531027)

Type: Patent office decision Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Europe (EPO)

Dr. G.Subrahmanyam opposition, Daclatasvir, (854/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

EP0521471 prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

Eldred Tellis and Ganesh Acharya opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)

Type: Patent opposition Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Emory University opposition, lamivudine (3TC) , (EP90301335)

Type: Patent opposition Drugs: Lamivudine Disease: HIV/AIDS Countries: Spain

Enzalutamide application, (PCT/US2006/011417)

Type: Patent application Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide application, (WO/2006/124118)

Type: Patent application Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide court case, (9668/DELNP/2007)

Type: Court case Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide decision, (9668/DELNP/2007 (WO/2006/124118))

Type: Patent office decision Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide decision, (9668/DELNP/2007)

Type: Patent office decision Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

European Public Health Alliance (EPHA) opposition, Sofosbuvir, (EP2604620)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Farmanguinhos opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

Farmanguinhos opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

Fresenius Kabi Oncology Limited opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Fresenius Kabi Oncology Limited opposition, Sorafenib, (1960/DELNP/2007)

Type: Patent opposition Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Fresenius Kabi Oncology Ltd opposition, Nilotinib, (9322/DELNP/2007)

Type: Patent opposition Drugs: Nilotinib Disease: Chronic Myeloid Leukaemia Countries: India

Fundación GEP and Red Argentina de Personas Positivas opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (AR 054060 A1)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))

Type: Patent opposition Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Sofosbuvir, (WO/2008/121634)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Argentina

GB2262229 prior art, (P000104057, P000104058)

Type: Prior art Drugs: Rosuvastatin Disease:

GS-5885+Ribavirin+other Anti-HCV Ledipasvir+Ribavirin+other Anti-HCV Compounds (GS5885+RBV+other Anti-HCV Compounds) application, (WO2011156757)

Type: Patent application Drugs: Ledipasvir+Ribavirin+Other Anti-HCV Compounds Disease: Hepatitis C

GSK656 application, (WO/2012/033858)

Type: Patent application Drugs: GSK3036656 Disease: Tuberculosis Countries: India

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Daclatasvir , (PI0716483-1 - WO2008021927)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Daclatasvir , (PI0716483-1)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Dolutegravir, (PI0610030-9 (US 2006/016604 - WO 2006/116764))

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9 - WO2005003147)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0809654-6 - WO2008121634)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6 - WO200208241)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir disoproxil fumarate/Emtricitabine, (PI0406760-6 - WO2004064845)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Velpatasvir, (BR112013012091-6)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: Brazil

GTPI opposition, Dolutegravir, (PI0610030-9 (WO2006116764))

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, Sofosbuvir, (PI0410846-9 e divisionais (PI0419342-­3, PI0419343-­1, PI0419344-­0, PI0419345-8) - WO2005003147)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI opposition, lopinavir/ritonavir (LPV/r) , (PI0413882­‐1)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9816239-0 (Divisional to PI9801145-4) )

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002757)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002758)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Ganesh Acharya opposition, GSK3036656, (602/KOLNP/2013)

Type: Patent opposition Drugs: GSK3036656 Disease: Tuberculosis Countries: India

Ganesh Acharya opposition, OPC-167832, (201737004817)

Type: Patent opposition Drugs: OPC-167832 (3,4-dihydrocarbostyril derivative Disease: Tuberculosis Countries: India

Glecaprevir application, (WO/2012/040167)

Type: Patent application Drugs: Glecaprevir Disease: HCV Countries: India

Grupo Plebio. Oscar Lizarazo. UAEM-UNAL-Colombia; Centro de Pensamiento, Medicamentos Información y Poder (Universidad Nacional) opposition, Nusinersen (Spinraza), (WO/2018/014041 PCT/US2017/042463 NC2019/0001236)

Type: Patent opposition Drugs: Nusinersen Disease: Spinal muscular atrophy (SMA Countries: Colombia

Gujarat State Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Henminlun opposition, Cabotegravir, (303371)

Type: Patent opposition Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Hepatitis Coalition, Nagaland (HepCon), Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai and Asia Pacific Network of Positive People (APN+), all of whom are represented by the Lawyers Collective opposition, daclatasvir, (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Imatinib court case, (1602/MAS/1998)

Type: Court case Drugs: Imatinib Disease: Chronic Myeloid Leukaemia Countries: India

India Cares Foundation opposition, Sofosbuvir, (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

India Cares opposition, Sofosbuvir, (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (2076/DEL/1997)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (896/DEL/2002 (divisional from 2174/DEL/1998))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (963/DEL/2002 (divisional to 2174/DEL/1998)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Karnataka Network of Positive People (KNP+) opposition, atazanavir (ATV) , (805/MAS/1997 )

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Manipur Network of Positive People (MNP+) opposition, zidovudine/lamivudine (AZT/3TC) , (2044/CAL/1997)

Type: Patent opposition Drugs: Zidovudine/Lamivudine Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Positive Women Network (PWN+) opposition, nevirapine (NVP) , (2485/DEL/1998)

Type: Patent opposition Drugs: Nevirapine Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Tamil Nadu Networking People with HIV/AIDS (TNNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) opposition, Raltegravir, (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) opposition, abacavir (ABC) , (872/CAL/98)

Type: Patent opposition Drugs: Abacavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+), Delhi Network of Positive People (DNP+) and Network of Maharashtra People with HIV (NMP+) opposition, lopinavir (LPV) , (IN/PCT/2002/1243/MUM)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Darunavir and Etravirine, (35/MUMNP/2010)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate cancer Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Simepravir, (10158/DELNP/2007)

Type: Patent opposition Drugs: Simepravir Disease: Hepatitis C Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Indian Pharmaceutical Alliance opposition, daclatasvir, (3372/CHENP/2012)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (3999/CHENP/2012 (PCT/US2010/055045))

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (806/DELNP/2010 (PCT/US2008/071734))

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Glecaprevir, (2891/DELNP/2013)

Type: Patent opposition Drugs: Glecaprevir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (9149/CHENP/2012)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir (GS7977) , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,964,580)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,284,342)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,633,309)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,735,372)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,393,256)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak), Delhi Network of Positive People (DNP+) and Indian Network of People Living with HIV/AIDS (INP+) opposition, lopinavir/ritonavir (LPV/r) , (IN/PCT/2001/01312/MUM)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Initiative for Medicines, Access and Knowledge (I-MAK) opposition, Sofosbuvir, (CN 200480019148.4)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: China

Initiative for Medicines, Access and Knowledge (I-MAK) opposition, Sofosbuvir, (CN 200880018024.2 (WO/2008/121634))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: China

Intermed Labs opposition, tenofovir disoproxil fumarate (TDF) , (602/DEL/2007 (Divisional from 2076/DEL/1997))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

International Preliminary Examination Report prior art, (PCT/US01/04813)

Type: Prior art Drugs: Sunitinib Disease: Cancer

Isoniazid-Rifapentine (3HP) application, (WO/2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)

Type: Patent opposition Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Europe (EPO)

Ledipasvir application, (WO/2010/132601)

Type: Patent application Drugs: Ledipasvir Disease: Hepatitis C Countries: India

Lenacapavir application, (WO/2018/035359)

Type: Patent application Drugs: Lenacapavir Disease: HIV Countries: India

Linezolid (Lzd) application, (WO/2001/057035 )

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: India

Linezolid (Lzd) application, (WO/2001/057035)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: India

Linezolid application, (WO/1995/007271)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: South Africa

Lopinavir (LPV) application, (WO/2001/74787 )

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Lopinavir (LPV) application, (WO/2002/018349)

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Lopinavir (LPV) application, (WO/2002/018349)

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Low-Voltage scanning Electron Microscope determination of nevirapine crystal habit in a pharmaceutical suspension prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

Lupin Ltd. opposition, Teneligliptin, (3176/KOLNP/2007)

Type: Patent opposition Drugs: Teneligliptin Disease: Diabetes Countries: India

MSN Laboratories Private Limited opposition, Ledipasvir, (9313/DELNP/2011)

Type: Patent opposition Drugs: Ledipasvir Disease: Hepatitis C Countries: India

Matrix Laboratories Ltd & Indian Network of People Living with HIV/AIDS (INP+) opposition, atazanavir (ATV) , (310/CHE/2007 (Divisional of 805/MAS/1997))

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, atazanavir (ATV) , (WO/2013/176772)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (259/MUMNP/2003)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (894/MUMNP/2007 (Divisional of IN/PCT/2002/1243/MUM))

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (1638/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (676/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (677/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Medicine Open Access Initiative (MOA-I) + SPM Corporation opposition, Sofosbuvir, (PCT/US2014/013953)

Type: Patent opposition Drugs: Sofosbuvir Disease: HCV Countries: Viet Nam

Merck, Novartis, Crucell Holand, Dr.Franz-Josef and Strawman opposition, Pneumococcal Conjugate Vaccine, (EP 1868645)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Miltenyi Biotec GmbH opposition, Tisagenlecleucel, (EP3214091)

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO)

Mr. Eldred Tellis opposition, Velpatasvir, (4351/DELNP/2013)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Mylan Laboratories India opposition, Raltegravir, (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV Countries: India

Mylan Laboratories India opposition, glatiramer acetate injection , (2234/DELNP/2007 (eq. PCT/US2005/032395 and US60/608,843))

Type: Patent opposition Drugs: Glatiramer acetate Disease: multiple sclerosis (MS Countries: India

Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (1732/MUMNP/2009)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (6733/DELNP/2007)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Médecins Sans Frontières (MSF) opposition, Sofosbuvir, (EP2604620)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Médecins Sans Frontières (MSF) opposition, Sofosbuvir/Velpatasvir, (CN 201480047195.3)

Type: Patent opposition Drugs: Sofosbuvir/Velpatasvir Disease: Hepatitis C Countries: China

Médecins Sans Frontières (MSF) opposition, Velpatasvir, (CN103328480A/CN201280004097.2)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: China

Médecins du Monde opposition, Sofosbuvir, (EP2203462)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Médecins du Monde opposition, Sofosbuvir, (EP2604620)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Médecins du Monde opposition, Tisagenlecleucel, (EP3214091 )

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Cancer Countries: Europe (EPO)

Nai Umang Positive Welfare Society opposition, Elvitegravir, (5576/DELNP/2008)

Type: Patent opposition Drugs: Elvitegravir Disease: HIV/AIDS Countries: India

Nandita Venkatesan and Phumeza Tisile (TB survivors) opposition, Bedaquiline Fumarate, (1220/MUMNP/2009)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Natco Pharma Ltd. opposition, Daclatasvir , (806/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Natco Pharma Ltd. opposition, Daclatasvir , (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Natco Pharma Ltd. opposition, Dasatinib , (4309/DELNP/2006)

Type: Patent opposition Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Natco Pharma Ltd. opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV Countries: India

Natco Pharma Ltd. opposition, Nilotinib, (9322/DELNP/2007)

Type: Patent opposition Drugs: Nilotinib Disease: Chronic Myeloid Leukaemia Countries: India

Natco Pharma Ltd. opposition, Paclitaxel, (2899/DELNP/2005)

Type: Patent opposition Drugs: Paclitaxel Disease: Cancer Countries: India

Natco Pharma Ltd. opposition, Sofosbuvir, (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Natco Pharma Ltd. opposition, Sorafenib, (1960/DELNP/2007)

Type: Patent opposition Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Network of Maharashtra People Living with HIV (NMP+) opposition, Bedaquiline, (1220/MUMNP/2009 (WO2008068231))

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Nilotinib application, (WO/2007/015871)

Type: Patent application Drugs: Nilotinib Disease: Chronic Myeloid Leukaemia Countries: India

Non-lipid-related effects of HMG-CoA reductase inhibitors prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

OPC-167832 application, (WO/2016/031255)

Type: Patent application Drugs: OPC-167832 (3,4-dihydrocarbostyril derivative Disease: Tuberculosis Countries: India

Optimus Pharma Ltd. opposition, Sofosbuvir, (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Optimus Pharma Ltd. opposition, Sofosbuvir, (WO/2008/121634)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Oscar Lizarazo (Plebio Research Group) opposition, CRISPR/Cas9, (WO/2013/176772 )

Type: Patent opposition Drugs: CRISPR/Cas9 Disease: Various Countries: Colombia

PCT/US98/12474 prior art, (IN/PCT/2002/1243/MUM )

Type: Prior art Drugs: Lopinavir Disease: HIV/AIDS

Paclitaxel application, (WO/2004/052401)

Type: Patent application Drugs: Paclitaxel Disease: Cancer Countries: India

Paclitaxel decision, (2899/DELNP/2005)

Type: Patent office decision Drugs: Paclitaxel Disease: Cancer Countries: India

Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)

Type: Patent opposition Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Europe (EPO)

Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (2533/KOLNP/2008)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (6666/CHENP/2012)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

People PLUS opposition, Lopinavir/Ritonavir, (EAPO № 011924)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Belarus

People Plus Non-Governmental Organization opposition, Lopinavir/Ritonavir, (PCT/US2004/027401 (EA11924))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Belarus

Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions prior art, (339/MUMNP/2006)

Type: Prior art Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS

Pibrentasvir application, (WO2012051361)

Type: Patent application Drugs: Pibrentasvir Disease: Hepatitis C Countries: India

Pneumococcal conjugate vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: pneumonia Countries: India

Poonam Singh opposition, Dasatinib , (4309/DELNP/2006)

Type: Patent opposition Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Prior Art used in I-Mak's opposition prior art, (339/MUMNP/2006)

Type: Prior art Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS

Public Eye opposition, Tisagenlecleucel, (EP3214091)

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO)

Raltegravir application, (WO/2006/060730)

Type: Patent application Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Raltegravir application, (WO/2011/053504)

Type: Patent application Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Raltegravir decision, (TH1201001892)

Type: Patent office decision Drugs: Raltegravir Disease: HIV/AIDS Countries: Thailand

Ranbaxy Laboratories opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Ranbaxy Laboratories opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Remdesivir application, (WO/2009/132123)

Type: Patent application Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: India

Remdesivir application, (WO/2009/132135)

Type: Patent application Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: India

Remdesivir application, (WO/2012/012776)

Type: Patent application Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: India

Remdesivir application, (WO/2012/012776)

Type: Patent application Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: India

Remdesivir application, (WO/2016/069826)

Type: Patent application Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: India

Sahara opposition, tenofovir disoproxil fumarate (TDF) , (2076/DEL/1997)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Sanjeev Sharma opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai opposition, Cabotegravir, (637/KOLNP/2013)

Type: Patent opposition Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Sankalp Rehabilitation Trust opposition, Telacebec, (8533/DELNP/2012)

Type: Patent opposition Drugs: Telacebec (Q203 Disease: Tuberculosis Countries: India

Sankalp Rehabilitation Trust opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sankalp Rehabilitation Trust, Hepatitis C Coalition of Nagaland (HepCon) and Asia Network of Positive People (APN+) opposition, Sofosbuvir , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sheela Pawar opposition, Enzalutamide, (9668/DELNP/2007)

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Sofosbuvir (GS7977) application, (WO/2008/121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

Sofosbuvir + Ledipasvir application, (WO/2014/120981)

Type: Patent application Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: India

Sofosbuvir + Ledipasvir decision, (BR112014011938)

Type: Patent office decision Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: Brazil

Sofosbuvir Prodrug application, (WO2008121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sofosbuvir Prodrug application, (WO/2008/121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Sofosbuvir Prodrug application, (WO/2008/121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: Russian Federation

Sofosbuvir application, (WO/2005/003147)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sofosbuvir application, (WO/2008/121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Sofosbuvir application, (WO/2008/121634)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sofosbuvir application, (WO2010135569)

Type: Patent application Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

Sofosbuvir decision, (6087/DELNP/2005)

Type: Patent office decision Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sofosbuvir decision, (6087/DELNP/2005)

Type: Patent office decision Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Sofosbuvir decision, (BR0809654-6)

Type: Patent office decision Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

Sofosbuvir decision, (BR0823519-8 divisional of BR0809654-6)

Type: Patent office decision Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

Sofosbuvir+Ribavirin (GS7977+RBV) application, (WO/2013/066748)

Type: Patent application Drugs: Sofosbuvir+Ribavirin Disease: Hepatitis C Countries: United States of America

Sofosbuvir/Velpatasvir application, (WO/2015/030853)

Type: Patent application Drugs: Sofosbuvir/Velpatasvir Disease: Hepatitis C Countries: India

Sofosbuvir/Velpatasvir application, (WO2015030853)

Type: Patent application Drugs: Sofosbuvir/Velpatasvir Disease: Hepatitis C Countries: India

Sorafenib application, (WO/2000/042012)

Type: Patent application Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Sorafenib application, (WO/2006/0349797)

Type: Patent application Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Sorafenib decision, (1960/DELNP/2007)

Type: Patent office decision Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Sorafenib decision, (IN/PCT/2001/00799/MUM (IN215758))

Type: Patent office decision Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Sridhar Prasangi opposition, Daclatasvir , (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Sunitinib application, (WO/2001/60814)

Type: Patent application Drugs: Sunitinib Disease: Cancer Countries: India

Sutezolid application, (WO/1995/007271)

Type: Patent application Drugs: Sutezolid Disease: Tuberculosis Countries: United States of America

Sutezolid application, (WO/2010/026526)

Type: Patent application Drugs: Sutezolid Disease: Tuberculosis Countries: United States of America

Sutezolid decision, (BR0417800)

Type: Patent office decision Drugs: Sutezolid Disease: Tuberculosis Countries: Brazil

Synthesis and biological activity of methanesulphonamide pyrimidine and N-methanesulphonyl pyrrole-sustituted 3,5-dihydroxy-6-heptanoates, a novel series of HMG-CoA reductasa inhibitors prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

Telacebec application, (WO/2011/113606 )

Type: Patent application Drugs: Telacebec (Q203 Disease: Tuberculosis Countries: India

Teneligliptin application, (WO/2006/088129)

Type: Patent application Drugs: Teneligliptin Disease: Diabetes Countries: India

Tenofovir Alafenamide Fumarate application, (WO/2002/08241)

Type: Patent application Drugs: Tenofovir Alafenamide Fumarate Disease: HIV Countries: India

Tenofovir Alafenamide Fumarate application, (WO/2002/08241)

Type: Patent application Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Tenofovir Alafenamide Fumarate application, (WO200208241)

Type: Patent application Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

Tenofovir Alafenamide Fumarate decision, (568/MUMNP/2011)

Type: Patent office decision Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Tenofovir disoproxil fumarate/Emtricitabine decision, (PI0406760-6 )

Type: Patent office decision Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

Tenofovir tenofovir disoproxil fumarate (TDF) decision, (1135/DEL/2007 (divisional to 896/DEL/2002))

Type: Patent office decision Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Textbook of practical organic chemistry prior art, (IN/PCT/2002/1243/MUM )

Type: Prior art Drugs: Lopinavir Disease: HIV/AIDS

Thai Network of People Living with HIV/AIDS (TNP+) opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (TH0401000086)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Thailand

The role of HMG-CoA reductasa inhibitors in the treatment of Hyperlipidemia: a review of fluvastatin prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

Tisagenlecleucel decision, (EP3214091 )

Type: Patent office decision Drugs: Tisagenlecleucel Disease: cancer Countries: Europe (EPO)

US Patent No. 5914332 prior art, (IN/PCT/2002/1243/MUM )

Type: Prior art Drugs: Lopinavir Disease: HIV/AIDS

US patent No. 5366972 prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

US patent No. 5620974 prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

Umesh Shah opposition, Enzalutamide, (9668/DELNP/2007)

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Uttar Pradesh Welfare for People Living with HIV/AIDS (UPNP+) and Indian Network of People Living with HIV/AIDS (INP+) opposition, amprenavir (AMP) , (727/DEL/1997)

Type: Patent opposition Drugs: Amprenavir Disease: HIV/AIDS Countries: India

Valganciclovir (VAL) application, (US6083953)

Type: Patent application Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Valganciclovir decision, (3350/CHENP/2009)

Type: Patent office decision Drugs: Valganciclovir Disease: Cytomegalovirus retinitis Countries: India

Vector Biosciences Pvt Ltd opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005) )

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Vector Biosciences Pvt Ltd opposition, Sofosbuvir, (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Velpatasvir application, (WO/2013/075029)

Type: Patent application Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Velpatasvir application, (WO2015191431)

Type: Patent application Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, lopinavir/ritonavir (LPV/r) , (1/2007/01909 )

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Viet Nam

Virupaksha Organics Limited opposition, Sofosbuvir, (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

WO9525504 prior art, (727/DEL/1997)

Type: Prior art Drugs: Amprenavir Disease: HIV/AIDS

WO9531217 prior art, (727/DEL/1997)

Type: Prior art Drugs: Amprenavir Disease: HIV/AIDS

WO9723200 prior art, (P000104057, P000104058)

Type: Prior art Drugs: Rosuvastatin Disease:

ZD-4522 ; Hypolipidemic HMG-CoA reductasa inhibitor prior art, (P000100408, P000104057, P000104058)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

abacavir (ABC) application, (WO/1998/52949)

Type: Patent application Drugs: Abacavir Disease: HIV/AIDS Countries: India

abacavir (ABC) decision, (872/CAL/98)

Type: Patent office decision Drugs: Abacavir Disease: HIV/AIDS Countries: India

amprenavir (AMP) application, ()

Type: Patent application Drugs: Amprenavir Disease: HIV/AIDS Countries: India

amprenavir (AMP) decision, (727/DEL/1997)

Type: Patent office decision Drugs: Amprenavir Disease: HIV/AIDS Countries: India

atazanavir (ATV) application, (WO/1997/40029)

Type: Patent application Drugs: Atazanavir Disease: HIV/AIDS Countries: India

atazanavir (ATV) application, (WO/2005/108349)

Type: Patent application Drugs: Atazanavir Disease: HIV/AIDS Countries: India

atazanavir (ATV) application, (WO/2005/108349)

Type: Patent application Drugs: Atazanavir Disease: HIV/AIDS Countries: India

atazanavir (ATV) decision, (6425/DELNP/2006)

Type: Patent office decision Drugs: Atazanavir Disease: HIV/AIDS Countries: India

atazanavir (ATV) decision, (805/MAS/1997 )

Type: Patent office decision Drugs: Atazanavir Disease: HIV/AIDS Countries: India

bedaquiline application, (WO/2004/011436)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

cyclobenzaprine decision, (P000104189)

Type: Patent office decision Drugs: Cyclobenzaprine Disease: Sleeping disorder Countries: Argentina

darunavir (DRV) application, (WO/2003/049746)

Type: Patent application Drugs: Darunavir+Ritonavir Disease: HIV/AIDS Countries: India

darunavir (DRV) decision, (1647/DELNP/2004 (WO/2003/049746))

Type: Patent office decision Drugs: Darunavir+Ritonavir Disease: HIV/AIDS Countries: India

darunavir (DRV) decision, (3598/DELNP/2004 (Crystal form) )

Type: Patent office decision Drugs: Darunavir Disease: HIV/AIDS Countries: India

darunavir (DRV) decision, (5301/DELNP/2006 (key intermediates))

Type: Patent office decision Drugs: Darunavir Disease: HIV/AIDS Countries: India

didanosine (ddl) court case, (Thai patent 7600)

Type: Court case Drugs: Didanosine Disease: HIV/AIDS Countries: Thailand

glatiramer acetate injection decision, (2234/DELNP/2007 (eq. PCT/US2005/032395 and US60/608,843))

Type: Patent office decision Drugs: Glatiramer acetate Disease: multiple sclerosis (MS Countries: India

imatinib (ITB) application, (WO/1999/03854)

Type: Patent application Drugs: Imatinib Disease: Cancer Countries: India

imatinib (ITB) court case, (1602/MAS/98 )

Type: Court case Drugs: Imatinib Disease: Cancer Countries: India

imatinib (ITB) court case, (1602/MAS/98 )

Type: Court case Drugs: Imatinib Disease: Cancer Countries: India

imatinib (ITB) decision, (1602/MAS/98 )

Type: Patent office decision Drugs: Imatinib Disease: Cancer Countries: India

interferon (IFN) decision, (1032/MAS/1997)

Type: Patent office decision Drugs: Interferon Disease: Hepatitis C Countries: India

lopinavir (LPV) decision, (IN/PCT/2002/1243/MUM )

Type: Patent office decision Drugs: Lopinavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) application, (WO/1997/21685)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

lopinavir/ritonavir (LPV/r) application, (WO/1997/21685)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

lopinavir/ritonavir (LPV/r) application, (WO/2000/74677)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) application, (WO/2005/039551)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) application, (WO/2005/039551)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) application, (WO/2005/039551)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) application, (WO/2005/039551)

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

lopinavir/ritonavir (LPV/r) application, (WO/2006/091529 )

Type: Patent application Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

lopinavir/ritonavir (LPV/r) court case, (PI1100397-9)

Type: Court case Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil